Semnur Pharmaceuticals, Inc. - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-09-26
4:10 pm
Purchase
2025-09-2213DSEMNUR PHARMACEUTICALS, INC. W
SMNRW
Scilex Holding Co
SCLX
188,554,849
79.890%
188,554,849increase
(New Position)
Filing
History